This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chaturvedi, A. K. Articles by Gillison, M. L. Search for Related Content PubMed PubMed Citation Articles by Chaturvedi, A. K. Articles by Gillison, M. L. Social Bookmarking                            What's this?

Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States

Anil K. Chaturvedi, Eric A. Engels, William F. Anderson, Maura L. Gillison

From the Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda; and the Johns Hopkins Medical Institutions, Baltimore, MD

Corresponding author: Maura L. Gillison, MD, PhD, Johns Hopkins University, Cancer Research Bldg I, Rm 3M 54A, 1650 Orleans St, Baltimore, MD 21231; e-mail: gillima{at}jhmi.edu

Purpose To investigate the impact of human papillomavirus (HPV) on the epidemiology of oral squamous cell carcinomas (OSCCs) in the United States, we assessed differences in patient characteristics, incidence, and survival between potentially HPV-related and HPV-unrelated OSCC sites.

Patients and Methods Data from nine Surveillance, Epidemiology, and End Results program registries (1973 to 2004) were used to classify OSCCs by anatomic site as potentially HPV-related (n = 17,625) or HPV-unrelated (n = 28,144). Joinpoint regression and age-period-cohort models were used to assess incidence trends. Life-table analyses were used to compare 2-year overall survival for HPV-related and HPV-unrelated OSCCs.

Results HPV-related OSCCs were diagnosed at younger ages than HPV-unrelated OSCCs (mean ages at diagnosis, 61.0 and 63.8 years, respectively; P < .001). Incidence increased significantly for HPV-related OSCC from 1973 to 2004 (annual percentage change [APC] = 0.80; P < .001), particularly among white men and at younger ages. By contrast, incidence for HPV-unrelated OSCC was stable through 1982 (APC = 0.82; P = .186) and declined significantly during 1983 to 2004 (APC = –1.85; P < .001). When treated with radiation, improvements in 2-year survival across calendar periods were more pronounced for HPV-related OSCCs (absolute increase in survival from 1973 through 1982 to 1993 through 2004 for localized, regional, and distant stages = 9.9%, 23.1%, and 18.6%, respectively) than HPV-unrelated OSCCs (5.6%, 3.1%, and 9.9%, respectively). During 1993 to 2004, for all stages treated with radiation, patients with HPV-related OSCCs had significantly higher survival rates than those with HPV-unrelated OSCCs.

Conclusion The proportion of OSCCs that are potentially HPV-related increased in the United States from 1973 to 2004, perhaps as a result of changing sexual behaviors. Recent improvements in survival with radiotherapy may be due in part to a shift in the etiology of OSCCs.

Supported by the Intramural Research Program of the National Cancer Institute and the National Institute of Dental and Craniofacial Research.

Presented in part at a Clinical Science Symposium at the 43rd Annual Meeting of the American Society of Clinical Oncology, June 1-5, 2007, Chicago, IL.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D. Rischin Oropharyngeal Cancer, Human Papilloma Virus, and Clinical Trials J. Clin. Oncol., January 1, 2010; 28(1): 1 - 3. [Full Text] [PDF]

				W. Shi, H. Kato, B. Perez-Ordonez, M. Pintilie, S. Huang, A. Hui, B. O'Sullivan, J. Waldron, B. Cummings, J. Kim, et al. Comparative Prognostic Value of HPV16 E6 mRNA Compared With In Situ Hybridization for Human Oropharyngeal Squamous Carcinoma J. Clin. Oncol., December 20, 2009; 27(36): 6213 - 6221. [Abstract] [Full Text] [PDF]

				C. H. Chung and M. L. Gillison Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications Clin. Cancer Res., November 15, 2009; 15(22): 6758 - 6762. [Abstract] [Full Text] [PDF]

				Q.-T. Le, J. Harris, A. M. Magliocco, C. S. Kong, R. Diaz, B. Shin, H. Cao, A. Trotti, J. T. Erler, C. H. Chung, et al. Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03 J. Clin. Oncol., September 10, 2009; 27(26): 4281 - 4286. [Abstract] [Full Text] [PDF]

				K. Settle, M. R. Posner, L. M. Schumaker, M. Tan, M. Suntharalingam, O. Goloubeva, S. E. Strome, R. I. Haddad, S. S. Patel, E. V. Cambell III, et al. Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients Cancer Prevention Research, September 1, 2009; 2(9): 776 - 781. [Abstract] [Full Text] [PDF]

				O. W. Brawley Oropharyngeal Cancer, Race, and the Human Papillomavirus Cancer Prevention Research, September 1, 2009; 2(9): 769 - 772. [Abstract] [Full Text] [PDF]

				A. K. Chaturvedi, M. M. Madeleine, R. J. Biggar, and E. A. Engels Risk of Human Papillomavirus-Associated Cancers Among Persons With AIDS J Natl Cancer Inst, August 19, 2009; 101(16): 1120 - 1130. [Abstract] [Full Text] [PDF]

				P.T. Hennessey, W.H. Westra, and J.A. Califano Human Papillomavirus and Head and Neck Squamous Cell Carcinoma: Recent Evidence and Clinical Implications Journal of Dental Research, April 1, 2009; 88(4): 300 - 306. [Abstract] [Full Text] [PDF]

				E. Winer, J. Gralow, L. Diller, B. Karlan, P. Loehrer, L. Pierce, G. Demetri, P. Ganz, B. Kramer, M. Kris, et al. Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology J. Clin. Oncol., February 10, 2009; 27(5): 812 - 826. [Abstract] [Full Text] [PDF]

				S. Marur and A. A. Forastiere Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment Mayo Clin. Proc., April 1, 2008; 83(4): 489 - 501. [Abstract] [Full Text] [PDF]